<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04840160</url>
  </required_header>
  <id_info>
    <org_study_id>lucymurray2016</org_study_id>
    <nct_id>NCT04840160</nct_id>
  </id_info>
  <brief_title>Influence of Tart Cherry Juice Intervention on Vascular Function</brief_title>
  <official_title>Influence of Tart Cherry Juice Intervention on Vascular Function and the Urinary Metabolite; a Preliminary Study to Inform Study Design</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northumbria University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northumbria University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diets containing fruit rich in anthocyanins have been shown (in meta-analyses) to be&#xD;
      beneficial for health, but intervention trials have shown inconsistent results. In this&#xD;
      preliminary study we want to investigate the influence of a tart-cherry juice intervention on&#xD;
      vascular function and explore metabolite profiles that may offer insight into their mechanism&#xD;
      of action&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease (CVD) is the primary cause of morbidity and mortality. Tart cherries&#xD;
      (TC) can positively impact major risk factors of CVD, activities thought to be related to&#xD;
      their phytochemical content. However, data from human trials is less clear. TC have been&#xD;
      shown to reduce systolic blood pressure (SBP) after acute, short-term and chronic intake, and&#xD;
      to improve vascular dysfunction, presumably due to their antioxidant and anti-inflammatory&#xD;
      activities. Other studies have not shown benefits of TC on SBP or vascular function and&#xD;
      studies are difficult to interpret with different populations, dosing and durations being&#xD;
      used as well as a lack of understanding for any underlying mechanisms. To account for the&#xD;
      latter, the use of metabolomics has become increasingly popular in nutritional research.&#xD;
      Therefore, the aim of this preliminary study was to characterise the effects of TC&#xD;
      supplementation on vascular function with a 4-week intervention and explore if metabolomics&#xD;
      can provide mechanistic evidence and this will inform for future chronic studies with TC&#xD;
      juice.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">August 1, 2019</completion_date>
  <primary_completion_date type="Actual">August 1, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Participants supplied with treatment or placebo in a plastic container</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic and diastolic blood pressure</measure>
    <time_frame>Change in blood pressure following 4 weeks intervention</time_frame>
    <description>Measurement of systolic and diastolic blood pressure before and after the intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial pulse wave velocity</measure>
    <time_frame>Change in pulse wave velocity following 4 weeks intervention</time_frame>
    <description>Measurement of pulse wave velocity before and after the intervention</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Digital volume pulse</measure>
    <time_frame>Change in digital volume pulse following 4 weeks intervention</time_frame>
    <description>Measurement of digital volume pulse before and after the intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Metabolomics</measure>
    <time_frame>Changes to urinary metabolite profiles following 4 weeks intervention</time_frame>
    <description>Ion intensities of ca 5000 metabolites in urine samples before and after the intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Dietary Exposure</condition>
  <condition>Metabolic Disturbance</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants supplied with 30 ml of a low fruit (&lt;1%) cordial mixed with maltodextrin and protein diluted in 100 ml water twice daily, once in the morning and evening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cherry juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants supplied with 30 ml of a tart cherry juice concentrate (CherryActive, United Kingdom; (containing 36.8 mg of anthocyanins) diluted in 100 ml of water twice daily, once in the morning and evening.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Cherry juice</intervention_name>
    <description>A tart cherry juice intervention</description>
    <arm_group_label>Cherry juice</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>A tart cherry juice placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  aged 19-40&#xD;
&#xD;
          -  no diagnosed issues with the ability to consume fruit juice&#xD;
&#xD;
          -  no known food intolerances to fruits&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  participants that are cigarette smokers&#xD;
&#xD;
          -  participants diagnosed with hypertension&#xD;
&#xD;
          -  participants diagnosed with any form of cardiometabolic diseases&#xD;
&#xD;
          -  participants that require any prescribed prescriptions excluding the contraceptive&#xD;
             pill&#xD;
&#xD;
          -  participants that are regular consumers of cherries (&gt;100 g/d)&#xD;
&#xD;
          -  participants that consume any antioxidant supplements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glyn Howatson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northumbria University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northumberland Building</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <zip>NE1 7ST</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 6, 2021</study_first_submitted>
  <study_first_submitted_qc>April 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2021</study_first_posted>
  <last_update_submitted>April 8, 2021</last_update_submitted>
  <last_update_submitted_qc>April 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cherry</keyword>
  <keyword>anthocyanin</keyword>
  <keyword>vascular function</keyword>
  <keyword>metabolomics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Research data will be shared on request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

